Scott Martin

1.9k citations

32 papers · 955 indexed · h-index 15

Impact in

Hepatology top 5%
- Hepatitis C virus research
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism

Papers in

Pharmacology 8
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 5
Issues, ethics and legal aspects 1

Co-authors: J. Romine Nicholas A. Meanwell Andy Pike Stephanie Harlfinger Dermot F. McGinnity Beth Williamson Donald R. O’Boyle Julie A. Lemm
Journals: Journal of Medicinal Chemistry (4 papers)Drug Metabolism and Disposition (4 papers)Rapid Communications in Mass Spectrometry (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)ACS Medicinal Chemistry Letters (2 papers)
Partner nations: United Kingdom United States Singapore

In The Last Decade

Scott Martin

29 papers receiving 919 citations

Peers

Countries citing papers authored by Scott Martin

Since Specialization

Citations

This map shows the geographic impact of Scott Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Martin more than expected).

Fields of papers citing papers by Scott Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Martin. The network helps show where Scott Martin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Scott Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Martin Line = papers co-authored together Scott Martin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A mismatch in enzyme-redox partnerships underlies divergent cytochrome P450 activities between human hepatocytes and microsomes Communications Biology ·Tashinga E. Bapiro, Scott Martin, Thomas S. Blacker, 山本潤, D. A. PISANENKO, Niresh Hariparsad, Rhys D.O. Jones, Michael R. Duchen, Stephanie Harlfinger	2025	0
2	The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors Drug Metabolism and Disposition ·Larissa Carolin Jagdschian, Bernard Barlaam, C. R. Diène, Eva M. Lenz, Scott Martin, Ujjal Sarkar, 山本潤, Andy Pike	2024	0
3	Drug metabolite identification using ultrahigh‐performance liquid chromatography–ultraviolet spectroscopy and parallelized scans on a tribrid Orbitrap mass spectrometer Rapid Communications in Mass Spectrometry ·山本潤, Scott Martin, D. A. PISANENKO, N.S.I. Sahidu, Barry Jones	2020	12
4	Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective Drug Discovery Today ·Andy Pike, Beth Williamson, Stephanie Harlfinger, Scott Martin, Dermot F. McGinnity	2020	155
5	Acute liver effects, disposition and metabolic fate of [14C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice Archives of Toxicology ·Kathryn Pickup, Scott Martin, E. A. Partridge, Huw B. Jones, Jonathan Wills, C.G Zamorano Vásquez, Alan J. McCarthy, Tuoya Wu Ren, Sylvain Julien-Lafferière, Beatriz Alderete Julca, Sunil Sarda, Ian D. Wilson	2016	3
6	Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor Drug Metabolism and Disposition ·Paul A. Dickinson, Mireille Cantarini, Stephan Giesler, Paul Frewer, Scott Martin, Kathryn Pickup, Peter Ballard	2016	105
7	The metabolic fate of [¹⁴C]-fenclozic acid in the hepatic reductase null (HRN) mouse Xenobiotica ·Kathryn Pickup, Jonathan Wills, Tuoya Wu Ren, Huw B. Jones, Sylvain Julien-Lafferière, Scott Martin, Sunil Sarda, Ian D. Wilson	2013	8
8	In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid Archives of Toxicology ·Tuoya Wu Ren, G., Scott Martin, Sunil Sarda, Timothy Schulz-Utermoehl, Simone H. Stahl, 仝宇红, Jelena Spremo, J. Gerry Kenna, Ian D. Wilson	2013	12
9	Reaction of Homopiperazine with Endogenous Formaldehyde: A Carbon Hydrogen Addition Metabolite/Product Identified in Rat Urine and Blood Drug Metabolism and Disposition ·Scott Martin, Eva M. Lenz, Kawada Yasuo, Martin Wild, Malcolm R. Clench	2012	5
10	Improved Auscultation Skills in Paramedic Students Using a Modified Stethoscope Journal of Emergency Medicine ·Erin L. Simon, Reza Yuliani Y, Nairmeen Haller, 徐琳君, Scott Martin, J. Aidan Carney, Muḥammad Ṣāliḥ ibn ʿAbd al-ʿAzīz Murād	2012	8
11	The metabolism of [14C]-zibotentan (ZD4054) in rat, dog and human, the loss of the radiolabel and the identification of an anomalous peak, derived from the animal feed Journal of Pharmaceutical and Biomedical Analysis ·Eva M. Lenz, Nestor Nestor Havyarimana, Scott Martin, Kawada Yasuo, David E. Heyd, Helen Tomkinson	2011	11
12	Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures Antimicrobial Agents and Chemotherapy ·Julie A. Lemm, John E. Leet, Donald R. O’Boyle, J. Romine, Xiaohua Huang, Daniel R. Schroeder, Jeffrey R. Alberts, Joseph L. Cantone, Jin-Hua Sun, Peter T. Nower, Scott Martin, Michael H. Serrano‐Wu, Nicholas A. Meanwell, Lawrence B. Snyder, Min Gao	2011	38
13	The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors Bioorganic & Medicinal Chemistry Letters ·Scott Martin, Peter W. Glunz, Brett R. Beno, Carl P. Bergstrom, J. Romine, E. Scott Priestley, Elise Balmand, Min Gao, Susan B. Roberts, Karen Rigat, Robert A. Fridell, Dike Qiu, Inio Asano, Ying-Kai Wang	2011	11
14	High‐throughput metabolic stability studies in drug discovery by orthogonal acceleration time‐of‐flight (OATOF) with analogue‐to‐digital signal capture (ADC) Rapid Communications in Mass Spectrometry ·Jan Gertheiss, Scott Martin, JOAO PAULO DE MOURA TEIXEIRA LEITE, Christopher R. Jones, Brian Middleton	2010	11
15	Identification of Hepatitis C Virus NS5A Inhibitors Journal of Virology ·Julie A. Lemm, Donald R. O’Boyle, Mengping Liu, Peter T. Nower, Richard J. Colonno, Milind Deshpande, Lawrence B. Snyder, Scott Martin, Denis R. St. Laurent, Michael H. Serrano‐Wu, J. Romine, Nicholas A. Meanwell, Min Gao	2009	149
16	Identification of the Thiophene Ring of Methapyrilene as a Novel Bioactivation-Dependent Hepatic Toxicophore Journal of Pharmacology and Experimental Therapeutics ·Fruin Mf, Chien-An Hu, عبدالحفيظ بلقاضي, James L. Maggs, Scott Martin, Martin Wild, Ian D. Wilson, John Harding, J. Gerry Kenna, Raimund M. Peter, Dominic P. Williams, Tsogt-Ochir Enkhbayar	2008	33
17	Dihydropyridine neuropeptide Y Y1 receptor antagonists 2 Bioorganic & Medicinal Chemistry ·Graham S. Poindexter, Marc A. Bruce, J. Guy Breitenbucher, Elisabeth Vogelheim, S.Y. Sit, J. Romine, Scott Martin, J. P. Walters, Rachel T. McGovern, Wendy Clarke, John W. Russell, Cristiano Puehler de Queiroz	2003	48
18	Novel Openers of Ca2+-Dependent Large-Conductance Potassium Channels: Symmetrical Pharmacophore and Electrophysiological Evaluation of Bisphenols Bioorganic & Medicinal Chemistry Letters ·Yi Li, Graham Johnson, J. Romine, Nicholas A. Meanwell, Scott Martin, Steven I. Dworetzky, Christopher G. Boissard, Valentin K. Gribkoff, John E. Starrett	2003	13
19	Dihydropyridine Neuropeptide Y Y1 Receptor Antagonists Bioorganic & Medicinal Chemistry Letters ·Graham S. Poindexter, Marc A. Bruce, Andi Nurwidah, Ivo Monković, Scott Martin, Eric M. Parker, Eurides Francisco, Rachel T. McGovern, Astrid Ortiz, Jennifer Stanley, Gail K. Mattson, Michael R. Kozlowski, Campieri Massimo, Cristiano Puehler de Queiroz	2002	30
20	Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid Journal of Medicinal Chemistry ·Nicholas A. Meanwell, J. Romine, Michael Rosenfeld, Scott Martin, Ashok K. Trehan, John J. Wright, Mary F. Malley, Jack Z. Gougoutas, Istabraq Hassan Abed Al-Had	1993	43

About Scott Martin

Scott Martin is a scholar working on Pharmacology, Issues, ethics and legal aspects, Hepatology, Pharmaceutical Science and Organic Chemistry, having authored 32 papers that have together received 955 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Quinazolinone synthesis and applications (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Hepatitis C virus research (4 papers), Synthesis and biological activity (3 papers), Ion channel regulation and function (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Hepatology (191 citations), Pharmacology (94 citations), Organic Chemistry (254 citations), Oncology (193 citations) and Molecular Biology (407 citations). Scott Martin has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include J. Romine, Nicholas A. Meanwell, Andy Pike, Stephanie Harlfinger, Dermot F. McGinnity, Beth Williamson, Donald R. O’Boyle, Julie A. Lemm, Michael H. Serrano‐Wu and Lawrence B. Snyder. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Rapid Communications in Mass Spectrometry, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact